The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of larotrectinib for children with newly diagnosed solid tumors and relapsed acute leukemias harboring TRK fusions: Children’s Oncology Group study ADVL1823.
 
Theodore Willis Laetsch
Consulting or Advisory Role - Bayer; Lilly; Loxo; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst)
 
Kathleen Ludwig
No Relationships to Disclose
 
Donald A. Barkauskas
Patents, Royalties, Other Intellectual Property - U.S. patent based on Ph.D. research in glioblastoma (I)
 
Steven G. DuBois
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Joan Ronan
No Relationships to Disclose
 
Erin R. Rudzinski
Honoraria - Cor2Ed (Inst)
Consulting or Advisory Role - Bayer (Inst)
 
Amanda Memken
No Relationships to Disclose
 
Joel Sorger
No Relationships to Disclose
 
Joel M. Reid
No Relationships to Disclose
 
Teena Bhatla
Consulting or Advisory Role - Janssen
 
April Nesin
No Relationships to Disclose
 
Brian D. Crompton
Employment - Acceleron Pharma (I); Mersana (I); Shire (I)
Stock and Other Ownership Interests - Acceleron Pharma (I); Mersana (I); Shire (I)
Research Funding - Gradalis
 
Alanna J. Church
Honoraria - Bio-Rad; The Jackson Laboratory
Consulting or Advisory Role - AlphaSights; Bayer; Perceptive Advisors; Perceptive Advisors; Samba Scientific; The Jackson Laboratory
Travel, Accommodations, Expenses - Bayer; The Jackson Laboratory
 
Elizabeth Fox
Research Funding - Ignyta (Inst); Novartis (Inst)
Other Relationship - Helsinn Therapeutics
 
Brenda Weigel
No Relationships to Disclose